Akamai Technologies

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.

Soak up the Boston city views from the 18th floor of Kendall Square. Next to biotech and IT industries, Kendall Square is ideally located in Cambridge, home of prestigious Harvard University. The building is tall and imposing, with mint green accents to truly stand out from the crowd. Located just a few minutes' drive from Boston Logan International Airport, Kendall Square is perfect for meeting guests, who you can have a working lunch with in one of the many neighboring restaurants and cafes.